Metraipolis › archive › dc_412dc315b26e

Anti-obesity medications and cognitive disorder risk: a discrepancy between RCTs and real-world evidence — Europe PMC PMID:42453588

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42453588
DOI
10.3389/fphar.2026.1859388
License (as archived)
solo-consultazione
Archived
2026-10-18T14:21:58.338Z
SHA-256 of the archived text
db3767c471f930a501e5ef0f31d56324e8e08b527dd1bc651534ac5ab043d01f
Stable URL of this page
https://metraipolis.com/documento/dc_412dc315b26e

How to cite

Anti-obesity medications and cognitive disorder risk: a discrepancy between RCTs and real-world evidence — Europe PMC PMID:42453588 — Europe PMC (en), https://europepmc.org/article/MED/42453588 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_412dc315b26e (Metraipolis archive dc_412dc315b26e, sha256 db3767c471f930a501e5ef0f31d56324e8e08b527dd1bc651534ac5ab043d01f)
BibTeX
@misc{dc412dc315b26e,
  title = {Anti-obesity medications and cognitive disorder risk: a discrepancy between RCTs and real-world evidence — Europe PMC PMID:42453588},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42453588},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_412dc315b26e; sha256 db3767c471f930a501e5ef0f31d56324e8e08b527dd1bc651534ac5ab043d01f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42453588. Agents can read the archived copy with the MCP tool read_document.